简介：
Overview
This protocol resolves common challenges experienced with sputum processing, facilitating its use with flow cytometry for high-throughput clinical diagnostics. It emphasizes the importance of accurate cell counting and re-suspension volume for successful flow cytometry analysis.
Key Study Components
Area of Science
- Flow Cytometry
- Cell Biology
- Lung Health Research
Background
- Sputum processing has historically posed challenges for flow cytometry.
- Accurate cell counts are crucial for effective analysis.
- Research areas include COPD, asthma, lung cancer, and COVID-19.
- This protocol aims to streamline sputum analysis for clinical diagnostics.
Purpose of Study
- To provide an efficient method for dissociating sputum into a single cell suspension.
- To characterize cellular subsets using standard flow cytometric platforms.
- To enhance research into lung health and related diseases.
Methods Used
- Determining antibody and dye staining volumes based on sputum weight.
- Performing cell counts during staining incubation.
- Utilizing flow cytometry for downstream analysis.
- Characterizing cellular subsets for research insights.
Main Results
- The protocol successfully dissociates sputum into single cell suspensions.
- Accurate cell counts are achieved, facilitating effective flow cytometry.
- Insights into lung health and disease mechanisms are provided.
- Streamlined process enhances clinical diagnostic capabilities.
Conclusions
- This protocol offers a reliable method for sputum analysis.
- It addresses previous challenges in sputum processing for flow cytometry.
- The findings support further research into lung-related diseases.
What is the main advantage of this protocol?
The protocol streamlines sputum processing for flow cytometry, saving time and improving accuracy.
How does this protocol improve cell counting?
It allows for cell counting during staining incubation, ensuring accurate re-suspension volumes.
What diseases can be studied using this method?
This method can be applied to research on COPD, asthma, lung cancer, and COVID-19.
Is this protocol suitable for high-throughput analysis?
Yes, it is designed for high-throughput clinical diagnostic purposes.
What platforms are used for characterization in this study?
Standard flow cytometric platforms are utilized for characterizing cellular subsets.
Can this protocol be adapted for other types of samples?
While focused on sputum, the principles may be adapted for other biological samples.
繁體中文
